CLINIBORG
About
Categories
Privacy Policy
Terms
Insulin Sliding Scales
Dec 21, 2024
•
Mark Morgan
categories:
endocrinology
pharmacology
This is an insulin sliding scale builder. The input boxes are too wide.
related link - Insulin Correction Dose for Hyperglycemia (calculator)
INSULIN SLIDING SCALE:
Sensitive - Total Daily Insulin Dose 20-42 units
Regular - Total Daily Insulin Dose 43-84 units
Resistant - Total Daily Insulin Dose 85-126 units
Custom
Blood Glucose Below 70: Give juice and seek medical attention
Blood Glucose 71-149: No Insulin
Blood Glucose 150-199: 1 unit Insulin
Blood Glucose 200-249: 2 units Insulin
Blood Glucose 250-299: 3 units Insulin
Blood Glucose 300-349: 4 units Insulin
Blood Glucose Over 350: 5 units Insulin and seek medical attention
Blood Glucose Below 70: Give juice and seek medical attention
Blood Glucose 71-149: No Insulin
Blood Glucose 150-199: 2 units Insulin
Blood Glucose 200-249: 4 units Insulin
Blood Glucose 250-299: 6 units Insulin
Blood Glucose 300-349: 8 units Insulin
Blood Glucose Over 350: 10 units Insulin and seek medical attention
Blood Glucose Below 70: Give juice and seek medical attention
Blood Glucose 71-149: No Insulin
Blood Glucose 150-199: 3 units Insulin
Blood Glucose 200-249: 6 units Insulin
Blood Glucose 250-299: 9 units Insulin
Blood Glucose 300-349: 12 units Insulin
Blood Glucose Over 350: 15 units Insulin and seek medical attention
Blood Glucose Below 70: Give juice and seek medical attention Blood Glucose 71-149: No Insulin Blood Glucose 150-199: 1 unit Insulin Blood Glucose 200-249: 2 units Insulin Blood Glucose 200-249: 3 units Insulin Blood Glucose 200-249: 4 units Insulin Blood Glucose Over 350: 5 units Insulin and seek medical attention
speech input
display/hide references
reference:
#1
Magaji, Vasudev, and Jann M. Johnston. Inpatient management of hyperglycemia and diabetes. Clinical Diabetes 29.1 (2011): 3.
Calculate The Result!
Reset Form
Result - Copy and paste this output:
Copy to Clipboard
Please enable JavaScript to view the
comments powered by Disqus.